Vowst restores gut microbiome balance using live biotherapeutic products, differing from traditional antibiotic treatments for C. difficile infections. Clinical trials showed Vowst significantly ...
difficile Infection with FDA and EU health authorities, per regulatory requirements. Phase 3 international trial planning continues to advance, using AI and other state-of-the-art techniques to ...